| MONDAY JUNE 10th, 2013 |
| 09:00-10:00 |
OPENING CEREMONY |
| 10:00-10:50 |
Keynote Lecture :TEVA Redefines the World of Health Care - All Means to an End of Better Patient Care"
Dr. Jeremy Levin, CEO Teva Pharmaceutical Industries, Israel |
| 10:50-11:40 |
Keynote Lecture : "Innovation in Cardiac Technology to Improve Patient Outcomes and Reduce Cost"
Pat Mackin, Senior Vice President and President of the Cardiac Rhythm Disease Management, Medtronic |
| 11:40-12:00 |
Coffee Break |
| 12:00-13:00 |
Panel Session :
"U.S. - ISRAELI Teams: The Multidisciplinary Path Toward Commercialization"
Moderator: Prof. Miriam Erez, The Mendes France Chair of Management & Economics, Technion Israel Institute of Technology
Dr. Ehud Cohen, CEO, BioControl Medical
Ori Hadomi, CEO, Mazor Robotics
Avner Halperin, CEO, EarlySense
Uri Yaron, Business Development, Cardiovascular Care and Haifa Technology Center. |
| 13:00-13:50 |
Lunch Break |
|
Companies and Academia Presentations |
| 13:50-14:10 |
V Wave: Interatrial Shunt for the Treatment of Chronic Heart Failure |
Foamix: Topical Minocycline: A New Modality for Skin Infection, Acne and Rosacea |
PhysiHome: Sports Injury Prevention and Rehabilitation |
Physio-logic: The New FDA Requirements and Policy for Acceptance of Foreign (OUS) Clinical Studies |
Angioslide: Changing Reimbursement Strategies - Real Life Examples |
Johnson & Johsnson: Creating Value Through Innovation and Collaboration |
Fuad Fares: Radioprotective Effectiveness of BP-C2 and BP-xC-1 on Radiation-induced Skin Damage |
| 14:10-14:30 |
NanoRetina: Sight Restoring, Small Implantable Artificial Retina |
Biogencell: CommercialiIzing Personalized Therapeutic Cellular Products |
Telesofia: Using Personalized Video to Clarify Medical Information |
Ramot - Maya Kotler: Panel on Animal Models – Different Approaches on Various Models |
Torreya Life Sciences Partners: Brain Ggame Changer - Israel as a Leader |
The Trendlines Group: Early-stage Investment in Israeli Medical Device Companies – Risk or Opportunity? |
Malka Shilo/Bar-Ilan University: Multifunctional Theranostic Nanoparticles for Alzheimer's Disease |
| 14:30-14:50 |
EarlySense: Setting a Gold Standard and Increasing Patient Safety |
NIHR- William Rosenberg: Development of a New DiagnosticTest for Liver Fibrosis |
MediSafe: Improved Drug Compliance, Improved Analytics, a Viable Business Model |
IOPtima: A Novel Glaucoma Laser Surgery |
Torys LLP: How Not to Negotiate a License Agreement |
Rotem Karni/Hebrew University: Alternative Splicing Changes as Predictive Markers for Personalized Medicine |
| 14:50-15:10 |
BrainsGate: Implantable device for the Treatment of CNS disorders |
Prolor Biotech: Leader in the Development of Next-Generation,Bio-better Long Acting Drugs |
Vaica Medical: The Economics of the Connected Patient |
Reglera: Managing FDA Inspections of Foreign Device Establishments
|
Galmedics: ActiLady the new therapeutic tampon that treats menstrual pain |
Ronit Sharon/Hebrew University: A Method For Early Diagnosis Of Parkinson’s Disease |
| 15:10-15:30 |
Chi2Gel: Hybrid Hydrogels for Painful Orthopedic and Rheumatologic Diseases |
Atox Bio: AB103, a Phase 2 Immunomodulator for NSTI (flesh eating bacteria) |
Millioni: The First Health Sharing Information Data Website for obese Patients |
Bioforum: Electronic Records in Healthcare Systems and Clinical Trials |
Respinova: New Treatment for Pulmonary Diseases |
Daphna Atlas/Hebrew University: AD4 (NAC amide; NACA) an Effective Potential Treatment for Age-Related Macular Degeneration (AMD)
|
| 15:30-15:50 |
Coffee Break |
| 15:50-16:10 |
Moebius Medical: MM-II - Better Bio-Lubricant Decreases Pain--Increases Function |
CellCure: Challenges in Developing Sight-Saving Cells |
NasVax: Novel Therapeutic Monoclonal Antibody with Broad Activity for Treating Alzheimer’s Disease (AD) |
Tavor: Novel Anterior Cruciate Ligament (ACL) Prosthesis |
Inspiro Medical: Innovative Dry Powder Drug Delivery Device
|
PRO-IV: A Mobile System, IMMGES, that Monitors and Manages IV Infusions at All Possible Settings |
Abraham Nudelman/Bar-Ilan University: A Derivative of an Antiviral Agent and a Histone Deacetylase Inhibitor Selectively Target Viral- and non-viral- Associated Malignancies |
| 16:10-16:30 |
Maxillent: The iRaise™ Sinus Lift Implant revolutionizing implant dentistry |
Chiasma: Pain Free, Self Administered Oral Drugs Replacing Injections |
Genom Complier: Democratizing the Tools of Creation |
PCI Pharmaceutical Consulting Israel: Israel’s Use of Outsourced GxP Services – A Growing and Important Trend |
Alcobra Pharma: A New Medication for ADHD |
Bioasscociate: How a Bio-Brand Strategy From Day Zero Can Significantly Improve Investability |
Tzachy Tal/Technion: Cell-Derived Liposomes for Drug-Delivery |
| 16:30-16:50 |
Apostherapy: A noninvasive Personal treatment of Neuromuscular Disorders |
KAMADA: Leading the Clinical Development of Alpha-1 Antitrypsin |
Algen Biopharmaceuticals: Targeting the Immune System to Iradicate Tumors |
Real Imaging: A Novel Technology for Breast Cancer Detection and Risk Assessment |
Nyxoah: Miniature Wireless Neurostimulator Controls Sleep Apnea |
SkyQuest Technologu Consulting: Twing Incubators: Promotion of Technology Internationalization |
Eli Breuer/Hebrew University: Identification of novel non-toxic, anti-cancer molecules regulating tumor microenvironment |
| 16:50-17:10 |
Orsense: From Analog to Digital Diagnostics – the case for noninvasive monitoring |
Orgenesis: Implementation of Advanced Autologous Cell-Based Therapy for Diabetic Patients |
Prestwick Chemical: Pharmacophores and Their Efficient Use for Ligand Profiling |
Imexco General: A Chronic Pain Detector |
CollPlant: Human Recombinant Collagen-Based Medical Devices for Orthopedic and Wound Healing Indications |
Global Cardiovascular Innovatiob Center: Israeli Technology. American Market - How do You Cross the Ocean? |
Uri Wormser/Hebrew University: Therapeutic Effects of Novel Peptides in Animal Model of Systemic Lupus Erythematosus |
| 17:10-17:30 |
NIHR Office for Clinical Research Infrastructure: Artificial Pancreas for children and adolescents with type-1 diabetes |
Macrocure: Curexcell-An innovative,Cell-Based Therapy for Treating Hard-to-Heal Wounds |
Neuroderm: An Emerging Pharmaceutical Company Delivering Therapies for CNS Diseases |
Neurokeeper Technologies: Automated Stroke Detection |
CartiHeal: Novel Implant for Cartilage Regeneration |
Yissum: New Ag-Bio Fund |
Ilana Kaspy/Hebrew University: Relacin, a Novel Antibacterial Agent Targeting the Stringent Response |
| 19:00-21:00 |
Biomed 2013 Welcome Cocktail |
| |
| TUESDAY 11TH JUNE 2013 |
| 09:00-09:30 |
Keynote Lecture :
Avi Hasson, Chief Scientist, Ministry of Industry, Trade and Labor |
| 09:30-10.20 |
Keynote Lecture:"Creating a Sustainable Innovation Portfolio in the Evolving Medical Device Sector"
Dr. Scott P. Bruder, Chief Medical and Scientific Officer, Stryker Corporation |
| 10:20-10:40 |
Naftali Bennett, Minister of Economy |
| 10.40-11.40 |
Keynote lecture: “60 Years to the Discovery of DNA : Genetics and Neuroscience – Towards New Therapeutic Strategies”
Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer
Dr. Sydney Brenner, 2002 Nobel Prize in Physiology or Medicine laureate
Dr.Eric S. Lander, Professor of Biology at the Massachusetts Institute of Technology (MIT), founding director of the Broad Institute of MIT and Harvard |
| 11:40-12:00 |
Coffee Break |
| 12:00-12:45 |
Keynote lecture: "The View of Pharma: Novel Models of Integrating External Innovation"
Dr. Uwe Schoenbeck, Chief Scientific Officer, External R$D Innovation (ERDI), Pfizer WorldwideResearch and Development |
| 12:45-13:45 |
Panel Session:
"Life Sciences Industry– A view to 2013"
Moderator: Jonathan Silverstein, General Partner, Orbimed
Dr. Graeme Martin, President and CEO, Takeda Ventures
Dr. Janis Naeve, Director, Amgen Ventures
Gwen Melincof, Senior Vice President, Business Development, Strategic Investment Group, Shire Pharmaceuticals
Philippe Goupit, Strategy and Business Development, Vice President Corporate Licenses, Sanofi
Zeev Zehavi, Vice President, Johnson & Johnson Development Corporation (JJDC)
Ron Laufer, Senior Managing Director of MedImmune Ventures |
| 13:45-14:50 |
Lunch Break |
|
Companies and Academia Presentations |
| 14:50-15:10 |
PrePex: Groundbreaking Device to Save Millions in Africa - Non Surgical Adult Male Circumcision for HIV Prevention |
Compugen: Identification and Validation of Novel Immune Checkpoint Targets for Cancer Immunotherapy |
Brainstorm: Autologous transplantation of mesenchymal stem cells in ALS patients is safe, with initial indications of clinical benefit: results of a Phase I/II clinical trial |
B.R.F. Engineering: Early Hematoma Detection (EHD) |
Melnik Oded Business Advisor: 20 Minutes on Intellectual Property (IP) Valuation |
University of Wisconsin: Innovations in Healthcare and its Commercialization |
Alex Binshtok/Hebrew University: Selective Anesthesia of Pain Fibers - The Magic Analgesic Bullet |
| 15:10-15:30 |
EyeYon Medical: Innovative Solutions for Corneal Edema |
Oramed: Oral Delivery Solutions for Drugs Currently Administered Via Injections |
Pluristem: Systemic Therapeutic Effect of Placental Expanded Cells (PLX) Following Local Administration in Hind Limb Ischemia Model |
Neetour Medical: Capno-Pulse is an Innovative Real-time Continuous, Non-invasive Technology to Measures PaCO2 |
Law Office of Joseph L. Felber: Public Experimentation’s Impact on Patentability |
BioJerusalem: Jeruslaem Based Biomed Companies Enjoy the Best Financial Incentives Available in Israe |
Simon Benita/Hebrew University: Novel Nano Delivery Systems of Hydrophilic Biomacromolecules for Improved Therapy |
| 15:30-15:50 |
Orscan: “Google Earth" of the Body: 3D Body Navigation for Medical Applications |
Marx Biotech: A novel Diagnostic kit for Graft Versus Host Disease (GVHD) |
Andromeda: DiaPep277®, an Innovative Treatment for Newly Diagnosed Type 1 Diabetes Patients |
Masmec S.p.A: SIRIO - the Innovative Technique for Early Diagnosis of Lung Cancer |
JMB Davis Ben-David: Picking up the Pieces: Patent Eligibility of Biotechnology in the U.S. in view of Prometheus and Myriad Genetics |
Academy for the Advancement of Science and Technology:Aging Cancer: Developing a Universal Treatment Without Adverse Effects" |
Meabco: BP-C1: New therapeutic strategy for the treatment of advanced cancer |
| 15:50-16:10 |
Leviticus-Cardio: Wireless Energy Transfer into the Body Enables New Medical Implant Devices |
GluSense: An implantable Glucose Sensor |
BiondVax: M-001: Universal Influenza Vaccine Active against Bird and Swine Pandemic Influenza Strains |
Ramot - Amit Gefen: System to Map Neuropathy in Extremities of Diabetic Patients |
Finnegan: What Makes the Patents of Some Medical Device Companies So Much More Valuable Than Others? |
Defined Health: Connecting Proof of Relevance™ to Proven Value for Pharma |
Dan Gazit/Hebrew University: Connecting Proof of Relevance™ to Proven Value for Pharma |
| 16:10-16:30 |
P - Cure: Adaptive Therapy -An Enabler in Expanding the use of Proton Therapy in Oncology Care |
Kadimastem: Pluripotent Stem Cells to Cure Diseases |
BioSight: Innovative Cancer Targeted Pro-Drugs |
Discover Medical Devices: Cardiac Patients on CPAP Have a New and Safer Option for Nocturnal Masks |
Mintz Levin: An overview of Post grant proceedings under the America Invents Act |
Abraham Niska/Tel Aviv University: The INHAND Project collaboration with the FDA on SEND (Standard for Exchange of Nonclinical Data) |
| 16:30-16:50 |
ExceeMatrix: Presenting High Tensile Strength Collagen |
BioLineRx: BL7010, Non-Absorbable Polymeric Sequestering Agent for Celiac Disease |
Kamidis: From Herbs to Drugs and Back |
Basad Medical: New generation of Dental Implants |
VEPatents: Purchasing and Commercialization of Patents |
Zeev Zalevsky/Bar-Ilan University: Non Invasive Ophthalmic Tactile Stimulation Device for Sensory Vision Substitution |
| 16:50-17:10 |
Coffee Break |
| 17:10-17:30 |
|
Syntezza Molecular Detection: Pathogen and Antibiotic Resistance Detection and Identification in Three Hours |
Polypid: A Novel Patented Nanotechnology Delivery Platform That Controls the Release Profile,Rate and Duration |
Advanced Inhalation Therapy: The Use of Nitric Oxide (NO) for Curing Serious Respiratory Infections |
Sughrue Mion PLLC: The Dawn of the America Invents Act - What you Should Know and How It Impacts Your Company |
PWC: Owning the Disease - The Most Successful New Business Model in Medical Technology |
Yael Mardor/Shiba Hospital: MRI-Based High Resolution Maps for Differentiating Tumor from Non-tumoral Tissues in Brain Tumor Patients |
| 17:30-17:50 |
Tensive: Vascularizable Biomaterials for Large Tissue Reconstruction |
Lipocure: BupigelTM - A Slow Release Prolonged Duration Local Anesthetic |
Peritech Pharma: A Specialty Anal-Rectal / women's health Pharmaceutical Company |
Elminda: BNA Technology for mapping & treatment brain disorders |
OCAD University (Toronto), Heenan Blaikie LLP (Canada): Patents, The new Healthcare panacea? |
Herold Braustein/Tel Aviv University: Diagnostics and Drug Delivery by “Intelligent” Polymer Shifting |
| 17:50-18:10 |
Ramot - Shmuel Einav: Very Short Peripheral Catheter for Reduction of Thrombosis |
Spring Biomed Ltd : Virtual Biopsy – Spectral analyses for breakthrough medical diagnostics in different medical applications. |
Regenecure: AMCA Bone Regeneration Membrane |
ClearCut: Innovative MRI System for Surface Imaging and Tissue Microstructure Assessment |
Mintz Levin: The Impact of Software Patents Have Played and Will Play on Healthcare Companies and Startups |
Pharma & Biotech Advisors srl: PharmaIsrael and Italy - A bridge4Innovation |
Jiin-Huey Chern Lin/National Cheng-Kung University: Osteoconductivity Study of Ti-7.5 Mo Alloy Implanted With Ca-Based Porous Granules as Implant-Bonegap Filler |
| 18:10-18:30 |
Galil Medical: Innovation and Developments in Cryoablation |
Aposense: Enhancing Drug Activity with Aposense Technology |
The College of Management Academic Studies: MBA - Bio-Medical Management - One of its kind in Israel! |
Biodata: We do Research…. Do we create Knowledge? |
Fish & Richardson: Patent Valuation - What Are Your Patents Worth? |
Novozymes: Collaborative Online Ideations: Diversity and Company Culture are Key for Rapid Adoption and Innovation |
Julian Tanner/University of Hong Kong: Nucleic Acid Aptamers for Malaria Diagnosis – Discovery, Structure and Application |
| 18:30-18:50 |
Ramot - Israel Gannot: Passive Accuratedetection of Elderly Patient Falling Events |
Starlet Derma: A Natural, Marine Extracted Micro-Injection Delivery Platform |
|
|
Finnigan: Traps for the Unwary- How Collaboration Agreements Can Adversly Impact Your Ability to Obtain U.S. Patents |
BiolineRx: Get Them While They're Young – BioLineRx's Early Development Program |
Insight Group - Fundación Universitaria de Ciencias de la Salud: Fractal And Euclidean Geometrical Diagnosis of Cervix Cytology |
| |
| WEDNESDAY 12TH JUNE 2013 |
| 09:00-09:30 |
Keynote Lecture - TBA |
| 09:30-10:20 |
Keynote Lecture: “Trends in Life Sciences: A Bankers's Perspective”
Douglas Solomon, Global Head of Medical Technology, Barclays
|
| 10:20-10:50 |
Coffee Break |
| 10:50-11:40 |
Keynote Lecture:"Implementation of Technology in the Hospital - A CEO's Perspective"
Dr. Monica Reed, CEO of Florida Hospital, Celebration, Florida U.S.A. |
| 11:40-12:30 |
Keynote Lecture : "The Evolving Role of Hospitals - A Glimpse at the Future and Impact on Manufacturers of Healthcare Products"
Dr. Des Cummings, President, Florida Hospital Foundation and EVP of Florida Hospital |
| 12:30-13:30 |
Lunch Break |
| |
Companies and Academia Presentations |
| 13:30-13:50 |
NanoMed Targeting System:A Nano-Magnetical Drug delivery system to treat Atrial Fibrillation (AF) |
KAHR:Targeted Fas-mediated Treatment of B-cell Lymphoma by Hexameric CTLA4-FasL |
Crescendo Enterprises : Road to China |
NeuroTrax:Internet -Based Medical Testing for Memory and Attention |
Include Consulting: The Regulatory Challenges For Combination Products |
Avalere Health: How Will Payment and Delivery Reforms Affect who Purchases Medical Devices in the U.S.A? Lessons in Product Commercialization and Demonstrating Value |
Hadassah Medical Center: BioDesign - Medical Innovation Accelerator |
| 13:50-14:10 |
Valtech Cardio: Developing Percutaneous Treatment of Mitral Valve Repair and Replacement |
VBL Therapeutics: Phase I/II Dose-Escalation Study of VB-111, an Anti-Angiogenic Gene therapy, in Patients withRecurrent Glioblastoma Multiforme (GBM) |
Lonza: Building Bridges From Research to Therapy-Enabling the Utilization of Human Induced Pluripotent Stem Cells for Clinical Therapies |
Inovytec: SALI™ The Next generation Pre-hospital Critical care device - You Can Save Lives |
NAMSA: China Market Entry for Medical Devices: Strategies for Success |
Hermona Soreq/Hebrew University: Testing the Effects of Deep Brain Stimulation in Parkinson’s Disease by Sequencing Blood Cell RNAs |
| 14:10-14:30 |
AFfix Medical: Virtual Bipolar Ultrasound Technology for the Treatment of Atrial Fibrilation |
Harlan: Compact MRI: An In-Vivo and Ex-Vivo Diagnostic Tool in Preclinical Release |
Alacrita: European Market Hurdles - The Grass Is Not Greener |
Todos Medical: Early Detection of Solid Tumors Using Fourier Transform Infrared Micro-Spectroscopy of Peripheral Blood |
AiM GmbH, Assessment-in Medicine: Choosing the First Tier Continent for Medical Devices – 510k Versus CE Mark |
Mintz Levin: Innovation in Era of Health Reform |
FGK Representative Service GmbH: The Role of The Legal Representative in Clinical Trials Conducted in The EU: What You Need to Know |
| 14:30-14:50 |
Vectorious Medical Technologies: Developing long-term Intra-cardiac hemodynamic indication system |
Vaxil BioTherapeutics: Novel T-cell Synthetic Vaccines for Both Therapeutic and Prophylactic Use |
Protea BioSciences Group: Dedicated Facility Offering Complete Support for the Most Advanced Mass Spectrometry Based Imaging Projects |
Real Imaging: A Novel Technology for Breast Cancer Detection and Risk Assessment |
Lumis International: How to Choose a CRO - Key Success Factors |
Maya Zigler/Hebrew University: Novel Targeted Therapy for Induction of Apoptosis and Immune Surveillance in EGFR Family Overexpressing Cancers |
| 14:50-15:10 |
Coffee Break |
| 15:10-15:30 |
HyPrevention: H.I.P CONCEPT®, Orthopedic Implant 2.0 - From Curative to Preventive Surgery |
Protalix Biotherapeutics: Advancing Oral Treatment for Gaucher Disease and Enzyme Replacement Therapy for Fabry Disease Into the Clinic |
Dabur Research Foundation: In Vitro Sscreening Tools to Accelerate New Drug Ddiscovery-Alternatives to Animal Testing |
PRO-IV: A Mobile System, IMMGES, that Monitors and Manages IV Infusions at All Possible Settings |
Mediclever Reimbursement Consultants: Lean Biomed Startup |
Salvius Legal B.V.: Managing Site Contracts for Multi-Country Trials |
BioImage:Advanced Imaging Methodologies for Biomedical, Healthcare and Life Sciences Fields" |
| 15:30-15:50 |
MCS: Non-Invasive Solutions for the Prevention of Deep Vein Thrombosis |
Applied Immune Technologies: Specializing in T-Cell Receptor-Like (TCRL) Antibodies |
Almac: Accelerated First in Human strategy |
LabStyle Innovations Dario: Telemedicine enabling personalization and Proactive Treatment Case Study: Dario For Diabetes |
GFA: Biosimilars – Similarity and Differences in The EU and US Requirements |
ExpreS2ion Biotechnologies: Efficient Expression of Challenging Proteins in S2 Cells |
|
| 15:50-16:10 |
ViDAC: Breakthrough Drugs for Cancer - Attacking the underlying |
Curewize Health: Improving Survival and Quality of Life of Young Cancer Patients |
Catalent Pharma Solutions: Using GPEx® Mammalian Cell Engineering Technology to Shorten Timelines, Reduce Risk, and Prepare for Success |
Gamida Cell:The Gamida Cell Chronicles: Diary of a Clinical Adventure |
NAMSA: Regenerative Medicine Cellular Therapies and Tissue Engineering Require a New Model for Preclinical and Clinical Research |
|
|
| 16:10-16:30 |
CIRTEC Medical Systems: The Challenges of Designing and Testing Miniaturized Implantable Devices |
Silenseed: Novel RNAi-Based Cancer Therapies |
Vetter Pharma International GmbH: Choosing a CDMO: Criteria to Help the Selection Process |
|
Law Offices of Irving L. Wiesen P.C: Lessons from FDA Warning Letters on Advertising, Marketing and Promotion |
|
|